Cardiovascular disease remains the leading cause of death in the United States, yet innovation in this space faces unique scientific, economic, and structural challenges.

In this episode of Bold Minds, Christine Winoto speaks with Lisa Suennen, Managing Partner of the American Heart Association Venture Fund, about what it really takes to move healthcare innovation from research to real world impact.

Lisa explains why the American Heart Association launched multiple venture funds, including a cardiac device fund, a social impact fund, a women’s health focused fund, and a venture studio, and how each addresses gaps that traditional venture capital often overlooks. She shares candid insights on why healthcare incentives remain misaligned, how venture capital can unintentionally make healthcare worse, and why many funded innovations fail to meaningfully improve patient and clinician experience.

The conversation also explores Lisa’s work as a writer and educator at UC Berkeley Haas School of Business, what she continues to repeat to founders and MBA students year after year, and why planning a career matters less than choosing the right people and learning environment.

This episode is a grounded look at mission driven venture capital, the realities of building healthcare companies, and what gives experienced investors hope in a system that often feels overwhelming.

Lisa Suennen's bio:

Lisa Suennen, Managing Partner with AHA Ventures for the American Heart Association, has spent over 35 years in healthcare and technology as venture capitalist, entrepreneur, operating executive, and strategy consultant. She has worked broadly across healthcare and life sciences, and especially where these sectors converge with technology.

Lisa is currently Managing Partner of American Heart Association Ventures, a multi-fund platform investing in companies across the full spectrum of healthcare and social determinants of health. She has also held General Partner roles at several venture funds, including Manatt Ventures, Psilos Group and GE Ventures, where she led the healthcare venture fund and sat on the overall GE Ventures Investment Committee. Lisa has also held executive-level operating roles at Canary Medical, Merit Behavioral Care and Manatt, Phelps & Phillips. Lisa was Co-founder and CEO of CSweetener, a company focused on matching mentors with rising healthcare leaders (sold to HLTH Foundation). She chairs the Scientific Advisory Board of the NASA -funded Translational Research Institute for Space Health and the International Investment Committee of the Australian & Victorian government-funded ANDHealth Digital Health Fund, and serves on the advisory boards of several emerging companies. Lisa is a Fellow of the Aspen Institute’s Health Innovators Fellowship and on faculty at the UC Berkeley Haas School of Business where she teaches the annual class on healthcare innovation and investment. Lisa writes the Venture Valkyrie blog and is an internationally recognized author and speaker.

Music Credit:

"Upbeat Corporate" by Music For Creators is licensed under CC BY (Creative Commons Attribution) via freemusicarchive.org.